Form 483

Sipra Labs Limited Form 483, 2014-03-01

FDA issued a Form 483 to Sipra Labs Limited on 2014-03-01 with 9 public-safe observations.

483· Form 483 issuedHuman Drugs9 observations

Sipra Labs Limited · Hyderabad, India · Issued March 1, 2014

Overview

  • 9 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

1 Mar 2014
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Barbara J Rincon

1 Mar 2014
21 CFR 211.52

Washing and toilet facilities are deficient

Cited by Barbara J Rincon

1 Mar 2014
21 CFR 211.86

Rotation of components/containers/closures

Cited by Barbara J Rincon

1 Mar 2014
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Barbara J Rincon

1 Mar 2014
21 CFR 211.100(b)

Procedure Deviations Recorded and Justified

Cited by Barbara J Rincon

Inspected site

SLSipra Labs LimitedHyderabad, India

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations2x
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.180(f)Cited across public-safe Form 483 observations1x
21 CFR 211.194(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.52Cited across public-safe Form 483 observations1x
21 CFR 211.86Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere